Literature DB >> 27259712

Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.

S S Ahmed1,2, E Alp3, A Ulu-Kilic3, G Dinc3,4, Z Aktas5, B Ada6, F Bagirova7, I Baran8, Y Ersoy9, S Esen10, T G Guven11, J Hopman12, S Hosoglu13, F Koksal11, E Parlak14, A N Yalcin15, G Yilmaz16, A Voss12, W Melchers12.   

Abstract

Epidemic clones of Acinetobacter baumannii, described as European clones I, II, and III, are associated with hospital epidemics throughout the world. We aimed to determine the molecular characteristics and genetic diversity between European clones I, II, and III from Turkey and Azerbaijan. In this study, a total of 112 bloodstream isolates of carbapenem-resistant Acinetobacter spp. were collected from 11 hospitals across Turkey and Azerbaijan. The identification of Acinetobacter spp. using conventional and sensitivity tests was performed by standard criteria. Multiplex polymerase chain reaction (PCR) was used to detect OXA carbapenemase-encoding genes (bla OXA-23-like, bla OXA-24-like, bla OXA-51-like, and bla OXA-58-like). Pulsed-field gel electrophoresis (PFGE) typing was used to investigate genetic diversity. The bla OXA-51-like gene was present in all 112 isolates, 75 (67 %) carried bla OXA-23-like, 7 (6.2 %) carried bla OXA-58-like genes, and 5 (4.5 %) carried bla OXA-24-like genes. With a 90 % similarity cut-off value, 15 clones and eight unique isolates were identified. The largest clone was cluster D, with six subtypes. Isolates from clusters D and I were widely spread in seven different geographical regions throughout Turkey. However, F cluster was found in the northern and eastern regions of Turkey. EU clone I was grouped within J cluster with three isolates found in Antalya, Istanbul, and Erzurum. EU clone II was grouped in the U cluster with 15 isolates and found in Kayseri and Diyarbakır. The bla OXA-24-like gene in carbapenemases was identified rarely in Turkey and has been reported for the first time from Azerbaijan. Furthermore, this is the first multicenter study in Turkey and Azerbaijan to identify several major clusters belonging to European clones I and II of A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27259712     DOI: 10.1007/s10096-016-2685-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Syrian refugees and infectious disease challenges.

Authors:  Hakan Leblebicioglu; Resat Ozaras
Journal:  Travel Med Infect Dis       Date:  2015 Nov-Dec       Impact factor: 6.211

2.  Stool screening of Syrian refugees and asylum seekers in Germany, 2013/2014: Identification of Sabin like polioviruses.

Authors:  Sindy Böttcher; Katrin Neubauer; Armin Baillot; Gabriele Rieder; Maja Adam; Sabine Diedrich
Journal:  Int J Med Microbiol       Date:  2015-08-21       Impact factor: 3.473

3.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  NDM-1-producing Acinetobacter baumannii ST85 now in Turkey, including one isolate from a Syrian refugee.

Authors:  Farzad Heydari; Caterina Mammina; Fatih Koksal
Journal:  J Med Microbiol       Date:  2015-07-14       Impact factor: 2.472

5.  Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia.

Authors:  Thierry Naas; Marc Levy; Claire Hirschauer; Hélène Marchandin; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

7.  Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.

Authors:  Canan Kulah; Marlies J Mooij; Fusun Comert; Elif Aktas; Guven Celebi; Nagihan Ozlu; Martine C Rijnsburger; Paul H M Savelkoul
Journal:  Int J Antimicrob Agents       Date:  2010-05-26       Impact factor: 5.283

8.  Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey.

Authors:  Gokhan Metan; Fatma Sariguzel; Bulent Sumerkan; Tanny van der Reijden; Lenie Dijkshoorn
Journal:  Infect Genet Evol       Date:  2012-12-01       Impact factor: 3.342

9.  Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii.

Authors:  Pauline D Mugnier; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

Review 10.  Management of septic shock and severe infections in migrants and returning travelers requiring critical care.

Authors:  E Alp; H Erdem; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-29       Impact factor: 3.267

View more
  8 in total

1.  Risk Assessment After a Severe Hospital-Acquired Infection Associated With Carbapenemase-Producing Pseudomonas aeruginosa.

Authors:  Joost Hopman; Corianne Meijer; Nikki Kenters; Jordy P M Coolen; Mohammad R Ghamati; Shaheen Mehtar; Reinout van Crevel; Wim J Morshuis; Ad F T M Verhagen; Michel M van den Heuvel; Andreas Voss; Heiman F L Wertheim
Journal:  JAMA Netw Open       Date:  2019-02-01

2.  Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii.

Authors:  Mohammad Hamidian; Steven J Nigro
Journal:  Microb Genom       Date:  2019-10

3.  Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period.

Authors:  A A van Driel; D W Notermans; A Meima; M Mulder; G A Donker; E E Stobberingh; A Verbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-22       Impact factor: 3.267

4.  Evaluation of bacteriophage cocktail on septicaemia caused by colistin-resistant Acinetobacter baumannii in immunocompromised mice model.

Authors:  Shesh Raj Patel; Chandra Bhan Pratap; Gopal Nath
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

5.  Adherence to and usefulness of the national treatment guideline for urinary tract infections (UTI) in a risk area.

Authors:  A A van Driel; M Mulder; E E Stobberingh; A Verbon
Journal:  BMC Prim Care       Date:  2022-09-07

6.  Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent.

Authors:  Ia Kusradze; Natia Karumidze; Sophio Rigvava; Teona Dvalidze; Malkhaz Katsitadze; Irakli Amiranashvili; Marina Goderdzishvili
Journal:  Front Microbiol       Date:  2016-10-04       Impact factor: 5.640

Review 7.  Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach.

Authors:  Iman Dandachi; Amer Chaddad; Jason Hanna; Jessika Matta; Ziad Daoud
Journal:  Front Microbiol       Date:  2019-08-23       Impact factor: 5.640

8.  Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of bla OXA-24-like and bla OXA-58-like genes.

Authors:  Niloofar Tafreshi; Laleh Babaeekhou; Maryam Ghane
Journal:  Iran J Microbiol       Date:  2019-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.